Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Fertiberia S A has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to examiner OLSEN, KAELEIGH ELIZABETH. The company's current prosecution involves a single distinct examiner and a sole distinct art unit, reflecting a concentrated focus on specific pharmaceutical research.
OLSEN, KAELEIGH ELIZABETH is the busiest examiner with 1 pending office action. For the practitioner, this means that the current success of the portfolio is tied to a single examiner relationship. Strategy should be developed with a deep understanding of this examiner's specific preferences and the administrative standards of the assigned art unit. As there are no other pending matters to offset potential delays, the practitioner must prioritize precise technical communication to advance this sole active application through the USPTO.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OLSEN, KAELEIGH ELIZABETH | 1 | 47.1% | +64.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18292818 | BIOLOGICAL COMPOSITION FOR NITRATE LEACHING PREVENTION | OLSEN, KAELEIGH ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18292818 | BIOLOGICAL COMPOSITION FOR NITRATE LEACHING PREVENTION | OLSEN, KAELEIGH ELIZABETH | 1619 | §103 | Final Rejection | — | Pending | Jan 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFertiberia S A has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Kaeleigh Elizabeth Olsen has the most, with 1 of Fertiberia S A's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.